Drug and Therapeutics Bulletin 1999;37:9-16; doi:10.1136/dtb.1999.3729
Copyright © 1999 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Tackling antimicrobial resistance

Relevant BNF section: 5.1

Bacteria resistant to antibiotic therapy are becoming much more common and this has led to mounting concern in the UK and worldwide.1–4 Many pathogens are now 'multiresistant', that is, they are resistant to several classes of antimicrobial drug. Infection with such organisms may be particularly difficult to treat. In this article, we briefly discuss how resistance and multiresistance occur. We consider some of the important pathogens involved and the problems they pose in hospitals and the community. We discuss strategies for slowing the accumulation of antibiotic resistance and the implications for doctors treating patients with common infections.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
S. Denamur, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Apoptosis Induced by Aminoglycosides in LLC-PK1 Cells: Comparative Study of Neomycin, Gentamicin, Amikacin, and Isepamicin Using Electroporation
Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2236 - 2238.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Risks of extended-spectrum beta-lactamases
DTB, March 1, 2008; 46(3): 21 - 24.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
H. Clements, T. Stephenson, V. Gabriel, T. Harrison, M. Millar, A. Smyth, W. Tong, and C. J Linton
Rationalised prescribing for community acquired pneumonia: a closed loop audit
Arch. Dis. Child., October 1, 2000; 83(4): 320 - 324.
[Abstract] [Full Text] [PDF]



About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1999 BMJ Publishing Group Ltd.